Thank you ASPC for this wonderful opportunity to attend the #ASPC2025 Congress as a scholarship recipient! Excited to learn and connect with colleagues and leaders in preventive cardiology. Michael D. Shapiro ASPC

I never knew someone would call me the Messi of Preventive Cardiology. I am not but so adore my Argentinian colleague Norberto Bornancini who is leading secondary prevention with #cardiacrehabilitation ⭐️ #ASPC2025

You know that #preventivecardiology has made it when the interventionalists decide to join us at #ASPC2025 CardioVisual: Powered by MedicalVisual Priya R. Kothapalli, MD, FACC, FSCAI

So much education at ASPC AND so much connection with these amazing friends and colleagues! If you’re not here, you should be! Join us next year! Danielle Belardo, MD

ASPC #ASPC2025 super session just starting on an impt topic & close to my ♥️ “Assessing Women’s #CV Risk across the #Lifespan” Super ⭐️⭐️⭐️⭐️⭐️⭐️ Faculty 👏👏 Opening with Alison L. Bailey, MD Dr. Kardie Tobb starts at Preconception #Prevention Planning 1/n

Dr. Kardie Tobb gives an outstanding talk on Preconception Prevention Planning #CVPrev #ASPC2025 🫀 identify those at risk: preconception planning 🫀 Modify cardiac meds 🫀 Team approach: organize the team 🫀 Discuss risks for optimal planning

Ijeoma Isiadinso MD MPH FACC FASNC discusses the role of prevention during & after reproduction #ASPC2025 🤰🏽Screen patients every time they are seen 🤰🏽Know the red flag 🚩 symptoms: not normal just because pregnant! 🤰🏽Use risk scores to assess risk CARPEG, ZAHARA 🤰🏽APOs occur in 10-20%

Dr. Isiadenso talks prevention during & after reproduction ✨pregnancy = stress test ✨black & Asian women have ⬆️ proportion of adverse pregnancy outcomes (Apo) ✨Hx of APO = risk enhancer for CVD ✨ACOG - low-dose ASA ⬇️ risk preeclampsia Very informative! ASPC

Lily N Dastmalchi DO, MA presenting on #menopause & CVRisk #ASPC2025 🫀menopause:long stage of life 🫀vasomotor symptoms affect 80% of women: ⤴️ CVD with frequent symptoms 🫀60% women have poor sleep in this stage: airway changes 🫀⤴️Lipids: LDL⤴️ assoc plaque 🫀weight gain, sarcopenia

Dr. Kerchberger now presenting on Geriatric Woman #ASPC2025 🫀the burden of CVD in against women is greater than in men 🫀SBP ⤴️ with age women >men; limited data of sex diff in management 🫀most older adults are inactive: need to help them get active 🫀need trials in older women

Dr Paul Ridker #ASPC2025 Risk Assessment ♥️ Need to assess risk earlier ♥️doctors won’t treat what they don’t measure ♥️✅ LDL, hsCRP, Lp(a): independently predict long term risk ♥️ Need to look at inflammatory risk: still ignored: beyond statins ♥️⤴️ hsCRP ⤴️ risk even w/⤵️LDL

NEJM Conclusion! #ASPC2025 ASPC Masterful talk by the amazing Dr. Ridker. We need to be listening to his voice now! Stay tuned for #ESCCongress

Dr. Plutzky explains the incretin effect: known in 1967 but this is GLP1-RA #CVprev #ASPC2025 🫀 adiposity is a risk factor for CVD 🫀#incretin therapies: ⤴️ evidence of ⤵️ CVD risk beyond weight loss: SELECT- 20%⤵️ in MACE

Dr. Aroda presents at #ASPC2025 on GLP-1RA & Outcomes 🫀the evolution of the discovery & effectiveness of therapies 🫀our meta analysis showed the effectiveness Frederick Berro Rivera, MD ⭐️ 🫀ADA now puts cardiometabolic phenotype dictates tx

Dr. Mantzoros presenting on the next frontier of tx of obesity #ASPC2025 ♥️MASLD: 1/3 have this! Excess fat in the liver needs to be diagnosed ♥️Associated with CVD outcomes ♥️acquiring understanding of mechanisms ♥️✅ FIB-4 index: often in EHR

Great session on hypertension at #ASPC2025 ⭐️Basics still matter➡️ Lifestyle ⭐️New pharmacological therapies show promise ⭐️Interventions like renal denervation can be complementary ➡️ Durable reduction in BP in the presence of lifestyle mod and max drug therapy Dr. Deepak L. Bhatt

#cardiology #cardiovascular #hypertension #cardiotwitter #cardioX ASPC

At ASPC 2025, Dr. Danielle Belardo Danielle Belardo, MD says 99% of supplements = ‘expensive urine’😬💊 Full interview coming soon. #ASPC2025 #CardioTwitter #EvidenceBasedCare

Couldn’t agree more #KeepItSimple Whom to treat: forgot #RiskScores rather think Imaging #SeeDiseaseTreatDisease #CAC What to treat/target: #LDL #Lpa #CRP Probably add #BP Single strategy better vs whole primary prevention guidelines 👇 Harlan Krumholz Michael J. Blaha Ron Blankstein

I always appreciate dialogue with Rob Ostfeld, MD, MSc , and in this interview he makes his stance clear on LDL and statins. ASPC X CardioVisual: Powered by MedicalVisual #aspc2025